DF
David F

1 reviews | Active since Aug 2011

15 Aug 2022, 13:35

This is for the Attention of Sharon Strydom CA(SA) Group chief Financial Officer Marco Tognocchi Director of Financial Services Lancet Laboratories.

This is for the Attention of Sharon Strydom CA(SA) Group chief Financial Officer Marco Tognocchi Director of Financial Services Lancet Laboratories.

Regretfully your Accounts division is unable to be of any assistance to me regarding an account going back to July 2021. I had the pleasure of talking to Winston at your JHB office this morning Monday 15 August 2022 in his defence he has politely promised to ESCALATE my query & to advise the bloodhounds to backoff on their demands for R207.00. Unfortunately as i have said on many occassions Escalate means I am passing the buck because quite frankly i dont give a rats ass about your problem... Some may say its a harsh critisism but I am yet to be proved wrong. All I do want to say at this stage is Credit Controllers need to be taught the diffrence between a Debit & a Credit before been unleashed on unsuspecting patients customers & even more so when you have ill equipped Collection Agencies doing your dirty work. Come on Lancet its not that difficult when you have a credit of R207.00 on one account & a shortfall of R207.00 on another account it DOESNT mean I owe R207.00 it means you need to pass the credit on to the account with a balance. Double entry principle DUH....

0
Replies (1)
Lancet
Lancet's reply16 Aug 2022, 09:09
Official
 Good day, thank you for bringing this to our attention, we have escalated the matter. Your reference number is: 2 5 8 7 3 3 4 . Regards, Lancet Laboratories.